Skip to main content
SpringerLink
Log in

AEs increase economic burden in patients with CLL

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2018 US dollars

Reference

  • Kabadi SM, et al. Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study. Advances in Therapy : 12 May 2020. Available from: URL: http://doi.oeg/10.1007/s12325-020-01350-w

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AEs increase economic burden in patients with CLL. PharmacoEcon Outcomes News 854, 4 (2020). https://doi.org/10.1007/s40274-020-6834-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6834-1

Search

Navigation